0002012886-24-000002.txt : 20240308 0002012886-24-000002.hdr.sgml : 20240308 20240307182919 ACCESSION NUMBER: 0002012886-24-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20240308 DATE AS OF CHANGE: 20240307 EFFECTIVENESS DATE: 20240308 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CoRegen, Inc. CENTRAL INDEX KEY: 0002012886 ORGANIZATION NAME: IRS NUMBER: 880685411 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-507023 FILM NUMBER: 24731811 BUSINESS ADDRESS: STREET 1: 600 E HOPKINS AVE STREET 2: STE 304 CITY: ASPEN STATE: CO ZIP: 81611 BUSINESS PHONE: 770-241-0270 MAIL ADDRESS: STREET 1: 600 E HOPKINS AVE STREET 2: STE 304 CITY: ASPEN STATE: CO ZIP: 81611 D 1 primary_doc.xml X0708 D LIVE 0002012886 CoRegen, Inc. 600 E HOPKINS AVE STE 304 ASPEN CO COLORADO 81611 770-241-0270 DELAWARE None None Corporation true 2022 John C. Thomas, Jr. 600 E. Hopkins Ave Ste 304 Aspen CO COLORADO 81611 Executive Officer Chief Financial Officer of the Issuer David Lonard, PhD 600 E. Hopkins Ave Ste 304 Aspen CO COLORADO 81611 Executive Officer Chief Science Officer of the Issuer Steve Gorlin 600 E. Hopkins Ave Ste 304 Aspen CO COLORADO 81611 Executive Officer Director Chief Executive Officer of the Issuer Bert W. O'Malley 600 E. Hopkins Ave Ste 304 Aspen CO COLORADO 81611 Director Clifford C. Dasco, M.D. 600 E. Hopkins Ave Ste 304 Aspen CO COLORADO 81611 Director Edward J. Benz, Jr. 600 E. Hopkins Ave Ste 304 Aspen CO COLORADO 81611 Director David M. Cornell, II 600 E. Hopkins Ave Ste 304 Aspen CO COLORADO 81611 Director Biotechnology Decline to Disclose 06b false 2022-08-09 true true Convertible Note convertible into Series A-2 Preferred Stock false 25000 M M Dillon & Co. LLC 19878 Elena Ulansky 7654267 1 Sound Shore Dr Ste 101 Greenwich CT CONNECTICUT 06830 FL FLORIDA false M M Dillion & Co. LLC 19878 Jeff Robert Swarz 1563420 1 Sound Shore Dr Ste 101 Greenwich CT CONNECTICUT 06830 NY NEW YORK false 12870000 12870000 0 false 31 84000 0 1013833 Director fees and executive compensation payments (includes amounts paid to a former director) false CoRegen, Inc. /s/ John C. Thomas, Jr. John C. Thomas, Jr. Chief Financial Officer of the Issuer 2024-03-07